Fera Pharmaceuticals

ferapharma.com

Fera is a specialty pharmaceutical company interested in acquiring and licensing ANDAs and NDAs, pursuing its own product development and partnering with companies in need of commercialization and marketing support.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Views and Analysis

ALTAMIRA THERAPEUTICS PROVIDES BUSINESS UPDATE AND FIRST HALF 2022 FINANCIAL RESULTS

Altamira Therapeutics Ltd | December 01, 2022

news image

Altamira Therapeutics Ltd. a company dedicated to developing therapeutics that address important unmet medical needs, today provided a business update and reported its first half 2022 financial results. “We continue to make good progress with the transformation of Altamira into an RNA delivery technology company. We are optimistic of reaching an agreement to divest or partner our Bentrio nasal spray for key markets in North America and Europe by year en...

Read More

Pharmacy Market

KAIROS PHARMA RECEIVED FDA APPROVAL OF THE IND APPLICATION FOR AN INVESTIGATIONAL NEW DRUG

Kairos Pharma, Ltd. | March 15, 2022

news image

Kairos Pharma, Ltd. a privately-held clinical-stage biotechnology company focused on cancer drug resistance and immunotherapy, announced today that its activated T cell therapy, KROS 201, has received FDA approval to move forward with a Phase 1 clinical trial in patients with recurrent glioblastoma. Kairos Pharma is funding the phase I trial, which will occur at Cedars Sinai Medical Center in Los Angeles. John Yu, M.D., Kairos CEO, commented, "This IND acceptance is the secon...

Read More

Business Insights

IKTOS ANNOUNCES COLLABORATION WITH GALAPAGOS IN AI FOR DRUG DESIGN

Iktos, | June 29, 2022

news image

Iktos, a company specialized in Artificial Intelligence for new drug design, announced a collaboration with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of Galapagos drug discovery programs. Under the agreement, Iktos will apply its de novo ligand and structure-based generative modelling technologies and software ...

Read More

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

news image

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More
news image

Views and Analysis

ALTAMIRA THERAPEUTICS PROVIDES BUSINESS UPDATE AND FIRST HALF 2022 FINANCIAL RESULTS

Altamira Therapeutics Ltd | December 01, 2022

Altamira Therapeutics Ltd. a company dedicated to developing therapeutics that address important unmet medical needs, today provided a business update and reported its first half 2022 financial results. “We continue to make good progress with the transformation of Altamira into an RNA delivery technology company. We are optimistic of reaching an agreement to divest or partner our Bentrio nasal spray for key markets in North America and Europe by year en...

Read More
news image

Pharmacy Market

KAIROS PHARMA RECEIVED FDA APPROVAL OF THE IND APPLICATION FOR AN INVESTIGATIONAL NEW DRUG

Kairos Pharma, Ltd. | March 15, 2022

Kairos Pharma, Ltd. a privately-held clinical-stage biotechnology company focused on cancer drug resistance and immunotherapy, announced today that its activated T cell therapy, KROS 201, has received FDA approval to move forward with a Phase 1 clinical trial in patients with recurrent glioblastoma. Kairos Pharma is funding the phase I trial, which will occur at Cedars Sinai Medical Center in Los Angeles. John Yu, M.D., Kairos CEO, commented, "This IND acceptance is the secon...

Read More
news image

Business Insights

IKTOS ANNOUNCES COLLABORATION WITH GALAPAGOS IN AI FOR DRUG DESIGN

Iktos, | June 29, 2022

Iktos, a company specialized in Artificial Intelligence for new drug design, announced a collaboration with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of Galapagos drug discovery programs. Under the agreement, Iktos will apply its de novo ligand and structure-based generative modelling technologies and software ...

Read More
news image

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us